Keshu Hu

机构：Fudan University Shanghai Cancer Center · ORCID：0000-0003-4576-3688

发表论文 25 篇 · 总被引 297 次 · h-index 11

代表论文

• IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages (2024 · Cell Death and Disease · 被引 34)
• Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma (2020 · Journal of Cancer · 被引 34)
• Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment (2022 · Cellular and Molecular Gastroenterology and Hepatology · 被引 33)
• Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy (2021 · International Journal of Hyperthermia · 被引 27)
• Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study (2024 · Nature Communications · 被引 26)
• Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment (2024 · Critical Reviews in Oncology/Hematology · 被引 21)